Table 1.

Expression of FLIP in human islets of type 2 diabetic patients

	Patient no.	Age, yr	BMI, kg/m2	FPG, mM	FLIP (saturation)
Diabetic	1	90	28.6	8.9	2
	2	87	30.8	14.3	1
	3	74	34.1	21.9	7
	4	71	29.1	13.4	2
	5	69	29.4	10	2
	6	65	27.6	10.3	5
Nondiabetic	7	50	19.6	5.5	27
	8	54	16.7	5.0	37
	9	81	29.4	5.5	18
	10	77	29.1	5.0	12
	11	78	20.3	4.4	43
	12	58	24.5	4.9	33

Saturation (change from background) of FLIP immunostaining in β cells of patients with type 2 diabetes and of nondiabetic control patients. BMI, body mass index; FPG, fasting plasma glucose.